The DOI matches its Crossref record; 232 of the 232 references it cites were found in a registry or an index.
Childhood cancer predisposition syndromes—A concise review and recommendations by the Cancer Predisposition Working Group of the Society for Pediatric Oncology and Hematology
Open accessAbstract
Heritable predisposition is an important cause of cancer in children and adolescents. Although a large number of cancer predisposition genes and their associated syndromes and malignancies have already been described, it appears likely that there are more pediatric cancer patients in whom heritable cancer predisposition syndromes have yet to be recognized. In a consensus meeting in the beginning of 2016, we convened experts in Human Genetics and Pediatric Hematology/Oncology to review the available data, to categorize the large amount of information, and to develop recommendations regarding when a cancer predisposition syndrome should be suspected in a young oncology patient. This review summarizes the current knowledge of cancer predisposition syndromes in pediatric oncology and provides essential information on clinical situations in which a childhood cancer predisposition syndrome should be suspected.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Identification of FAP Locus Genes from Chromosome 5q21
Kinzler, K. W., Nilbert, M. C., Su, L.-K., Vogelstein, B., Bryan, T. M., Levy, D. B., Smith, K. J., Preisinger, A. C., Hedge, P., McKechnie, D., et al. (1991) · Science · doi:10.1126/science.1651562 · Cited by 2,355
Liaw, D., Marsh, D. J., Li, J., Dahia, P. L. M., Wang, S. I., Zheng, Z., Bose, S., Call, K. M., Tsou, H. C., Peacoke, M., et al. (1997) · Nature Genetics · doi:10.1038/ng0597-64 · Cited by 2,091
CONSENSUS: Guidelines for Diagnosis and Therapy of MEN Type 1 and Type 2
Brandi, M. L. (2001) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.12.5658 · Cited by 2,031
Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A
Mulligan, L. M., Kwok, J. B. J., Healey, C. S., Elsdon, M. J., Eng, C., Gardner, E., Love, D. R., Mole, S. E., Moore, J. K., Papi, L., et al. (1993) · Nature · doi:10.1038/363458a0 · Cited by 1,966
TERT Promoter Mutations in Familial and Sporadic Melanoma
Horn, S., Figl, A., Rachakonda, P. S., Fischer, C., Sucker, A., Gast, A., Kadel, S., Moll, I., Nagore, E., Hemminki, K., et al. (2013) · Science · doi:10.1126/science.1230062 · Cited by 1,799
The Multiple Leiomyoma Consortium (2002) · Nature Genetics · doi:10.1038/ng849 · Cited by 1,635
Schmidt, L., Duh, F.-M., Chen, F., Kishida, T., Glenn, G., Choyke, P., Scherer, S. W., Zhuang, Z., Lubensky, I., Dean, M., et al. (1997) · Nature Genetics · doi:10.1038/ng0597-68 · Cited by 1,524
Clinical Practice Guidelines for Multiple Endocrine Neoplasia Type 1 (MEN1)
Thakker, R. V., Newey, P. J., Walls, G. V., Bilezikian, J., Dralle, H., Ebeling, P. R., Melmed, S., Sakurai, A., Tonelli, F., & Brandi, M. L. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1230 · Cited by 1,477
Frequent Mutation of BAP1 in Metastasizing Uveal Melanomas
Harbour, J. W., Onken, M. D., Roberson, E. D. O., Duan, S., Cao, L., Worley, L. A., Council, M. L., Matatall, K. A., Helms, C., & Bowcock, A. M. (2010) · Science · doi:10.1126/science.1194472 · Cited by 1,462
Identification of ALK as a major familial neuroblastoma predisposition gene
Mossé, Y. P., Laudenslager, M., Longo, L., Cole, K. A., Wood, A., Attiyeh, E. F., Laquaglia, M. J., Sennett, R., Lynch, J. E., Perri, P., et al. (2008) · Nature · doi:10.1038/nature07261 · Cited by 1,407
Germ-Line Mutations in Nonsyndromic Pheochromocytoma
Neumann, H. P. H., Bausch, B., McWhinney, S. R., Bender, B. U., Gimm, O., Franke, G., Schipper, J., Klisch, J., Altehoefer, C., Zerres, K., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020152 · Cited by 1,367
Germline Mutations in Predisposition Genes in Pediatric Cancer
Zhang, J., Walsh, M. F., Wu, G., Edmonson, M. N., Gruber, T. A., Easton, J., Hedges, D., Ma, X., Zhou, X., Yergeau, D. A., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1508054 · Cited by 1,345
Peutz-Jeghers syndrome is caused by mutations in a novel serine threoninekinase
Jenne, D. E., Reomann, H., Nezu, J.-I., Friedel, W., Loff., S., Jeschke, R., Müller, O., Back, W., & Zimmer, M. (1998) · Nature Genetics · doi:10.1038/ng0198-38 · Cited by 1,205
Kirschner, L. S., Carney, J. A., Pack, S. D., Taymans, S. E., Giatzakis, C., Cho, Y. S., Cho-Chung, Y. S., & Stratakis, C. A. (2000) · Nature Genetics · doi:10.1038/79238 · Cited by 1,153
Hofstra, R. M. W., Landsvater, R. M., Ceccherini, I., Stulp, R. P., Stelwagen, T., Luo, Y., Pasini, B., Hoppener, J. W. M., van Amstel, H. K. P., Romeo, G., et al. (1994) · Nature · doi:10.1038/367375a0 · Cited by 1,149
Song, W.-J., Sullivan, M. G., Legare, R. D., Hutchings, S., Tan, X., Kufrin, D., Ratajczak, J., Resende, I. C., Haworth, C., Hock, R., et al. (1999) · Nature Genetics · doi:10.1038/13793 · Cited by 1,100
Tartaglia, M., Niemeyer, C. M., Fragale, A., Song, X., Buechner, J., Jung, A., Hählen, K., Hasle, H., Licht, J. D., & Gelb, B. D. (2003) · Nature Genetics · doi:10.1038/ng1156 · Cited by 1,033
Self-citationMultiple endocrine neoplasia type 1 gene maps to chromosome 11 and is lost in insulinoma
Larsson, C., Skogseid, B., Öberg, K., Nakamura, Y., & Nordenskjöld, M. (1988) · Nature · doi:10.1038/332085a0 · Cited by 1,028
The CORGI Consortium, Palles, C., The WGS500 Consortium, Cazier, J.-B., Howarth, K. M., Domingo, E., Jones, A. M., Broderick, P., Kemp, Z., Spain, S. L., et al. (2013) · Nature Genetics · doi:10.1038/ng.2503 · Cited by 997
Germline p16 mutations in familial melanoma
Hussussian, C. J., Struewing, J. P., Goldstein, A. M., Higgins, P. A. T., Ally, D. S., Sheahan, M. D., Clark, W. H., Tucker, M. A., & Dracopoli, N. C. (1994) · Nature Genetics · doi:10.1038/ng0994-15 · Cited by 977
Pelletier, J., Bruening, W., Kashtan, C. E., Mauer, S. M., Manivel, J. C., Striegel, J. E., Houghton, D. C., Junien, C., Habib, R., & Fouser, L. (1991) · Cell · doi:10.1016/0092-8674(91)90194-4 · Cited by 954
Nevoid Basal-Cell Carcinoma Syndrome
GORLIN, R. J. (1987) · Medicine · doi:10.1097/00005792-198703000-00002 · Cited by 883
Rausch, T., Jones, D. T. W., Zapatka, M., Stütz, A. M., Zichner, T., Weischenfeldt, J., Jäger, N., Remke, M., Shih, D., Northcott, P. A., et al. (2012) · Cell · doi:10.1016/j.cell.2011.12.013 · Cited by 865
Self-citationBouffet, E., Larouche, V., Campbell, B. B., Merico, D., de Borja, R., Aronson, M., Durno, C., Krueger, J., Cabric, V., Ramaswamy, V., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2016.66.6552 · Cited by 857
Germ-line and acquired mutations of INI1 in atypical teratoid and rhabdoid tumors.
Biegel, J. A., Zhou, J. Y., RORKE, L. B., Stenstrom, C., Wainwright, L. M., & Fogelgren, B. (1999) · PubMed · Cited by 836
Stratakis, C. A., Kirschner, L. S., & Carney, J. A. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.9.4041 · Cited by 826
Genome Sequencing of SHH Medulloblastoma Predicts Genotype-Related Response to Smoothened Inhibition
Kool, M., Jones, D. T. W., Jäger, N., Northcott, P. A., Pugh, T. J., Hovestadt, V., Piro, R. M., Esparza, L. A., Markant, S. L., Remke, M., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.02.004 · Cited by 762
Self-citationDICER1 Mutations in Familial Pleuropulmonary Blastoma
Hill, D. A., Ivanovich, J., Priest, J. R., Gurnett, C. A., Dehner, L. P., Desruisseau, D., Jarzembowski, J. A., Wikenheiser-Brokamp, K. A., Suarez, B. K., Whelan, A. J., et al. (2009) · Science · doi:10.1126/science.1174334 · Cited by 751
Donor splice-site mutations in WT1 are responsible for Frasier syndrome
Barbaux, S., Niaudet, P., Gubler, M.-C., Grünfeld, J.-P., Jaubert, F., Kuttenn, F., Fékété, C. N., Souleyreau-Therville, N., Thibaud, E., Fellous, M., et al. (1997) · Nature Genetics · doi:10.1038/ng1297-467 · Cited by 751
The genomic landscape of hypodiploid acute lymphoblastic leukemia
Holmfeldt, L., Wei, L., Diaz-Flores, E., Walsh, M., Zhang, J., Ding, L., Payne-Turner, D., Churchman, M., Andersson, A., Chen, S.-C., et al. (2013) · Nature Genetics · doi:10.1038/ng.2532 · Cited by 731
Germline KRAS mutations cause Noonan syndrome
Schubbert, S., Zenker, M., Rowe, S. L., Böll, S., Klein, C., Bollag, G., van der Burgt, I., Musante, L., Kalscheuer, V., Wehner, L.-E., et al. (2006) · Nature Genetics · doi:10.1038/ng1748 · Cited by 730
Self-citationHereditary Cancer Predisposition Syndromes
Garber, J. E., & Offit, K. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.10.042 · Cited by 697
Biallelic mutations in PALB2 cause Fanconi anemia subtype FA-N and predispose to childhood cancer
Reid, S., Schindler, D., Hanenberg, H., Barker, K., Hanks, S., Kalb, R., Neveling, K., Kelly, P., Seal, S., Freund, M., et al. (2007) · Nature Genetics · doi:10.1038/ng1947 · Cited by 642
Self-citationGermline mutations of the gene encoding bone morphogenetic protein receptor 1A in juvenile polyposis
Howe, J. R., Bair, J. L., Sayed, M. G., Anderson, M. E., Mitros, F. A., Petersen, G. M., Velculescu, V. E., Traverso, G., & Vogelstein, B. (2001) · Nature Genetics · doi:10.1038/88919 · Cited by 629
Constitutional aneuploidy and cancer predisposition caused by biallelic mutations in BUB1B
Hanks, S., Coleman, K., Reid, S., Plaja, A., Firth, H., FitzPatrick, D., Kidd, A., Méhes, K., Nash, R., Robin, N., et al. (2004) · Nature Genetics · doi:10.1038/ng1449 · Cited by 605
Villani, A., Shore, A., Wasserman, J. D., Stephens, D., Kim, R. H., Druker, H., Gallinger, B., Naumer, A., Kohlmann, W., Novokmet, A., et al. (2016) · The Lancet Oncology · doi:10.1016/s1470-2045(16)30249-2 · Cited by 546
Exome sequencing identifies MAX mutations as a cause of hereditary pheochromocytoma
Comino-Méndez, I., Gracia-Aznárez, F. J., Schiavi, F., Landa, I., Leandro-García, L. J., Letón, R., Honrado, E., Ramos-Medina, R., Caronia, D., Pita, G., et al. (2011) · Nature Genetics · doi:10.1038/ng.861 · Cited by 526
A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma
Bertolotto, C., Lesueur, F., Giuliano, S., Strub, T., de Lichy, M., Bille, K., Dessen, P., d’Hayer, B., Mohamdi, H., Remenieras, A., et al. (2011) · Nature · doi:10.1038/nature10539 · Cited by 526
De novo mutations of SETBP1 cause Schinzel-Giedion syndrome
Hoischen, A., van Bon, B. W. M., Gilissen, C., Arts, P., van Lier, B., Steehouwer, M., de Vries, P., de Reuver, R., Wieskamp, N., Mortier, G., et al. (2010) · Nature Genetics · doi:10.1038/ng.581 · Cited by 489
Subgroup-Specific Prognostic Implications of TP53 Mutation in Medulloblastoma
Zhukova, N., Ramaswamy, V., Remke, M., Pfaff, E., Shih, D. J. H., Martin, D. C., Castelo-Branco, P., Baskin, B., Ray, P. N., Bouffet, E., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.48.5052 · Cited by 485
Self-citationCancer in dyskeratosis congenita
Alter, B. P., Giri, N., Savage, S. A., & Rosenberg, P. S. (2009) · Blood · doi:10.1182/blood-2008-12-192880 · Cited by 478
Constitutional Mutations of the hSNF5/INI1 Gene Predispose to a Variety of Cancers
Sévenet, N., Sheridan, E., Amram, D., Schneider, P., Handgretinger, R., & Delattre, O. (1999) · The American Journal of Human Genetics · doi:10.1086/302639 · Cited by 450
Bertherat, J., Horvath, A., Groussin, L., Grabar, S., Boikos, S., Cazabat, L., Libe, R., René-Corail, F., Stergiopoulos, S., Bourdeau, I., et al. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-2333 · Cited by 449
Inherited and Somatic Defects in DDX41 in Myeloid Neoplasms
Polprasert, C., Schulze, I., Sekeres, M. A., Makishima, H., Przychodzen, B., Hosono, N., Singh, J., Padgett, R. A., Gu, X., Phillips, J. G., et al. (2015) · Cancer Cell · doi:10.1016/j.ccell.2015.03.017 · Cited by 434
Mutations in PTPN11 implicate the SHP-2 phosphatase in leukemogenesis
Loh, M. L. (2004) · Blood · doi:10.1182/blood-2003-09-3287 · Cited by 427
Developmental defects in gorlin syndrome related to a putative tumor suppressor gene on chromosome 9
Gailani, M. R., Bale, S. J., Leffell, D. J., DiGiovanna, J. J., Peck, G. L., Poliak, S., Drum, M. A., Pastakia, B., McBride, O. W., Kase, R., et al. (1992) · Cell · doi:10.1016/0092-8674(92)90122-s · Cited by 423
Boikos, S. A., Pappo, A. S., Killian, J. K., LaQuaglia, M. P., Weldon, C. B., George, S., Trent, J. C., von Mehren, M., Wright, J. A., Schiffman, J. D., et al. (2016) · JAMA Oncology · doi:10.1001/jamaoncol.2016.0256 · Cited by 416
Germline Mutation of INI1/SMARCB1 in Familial Schwannomatosis
Hulsebos, T. J. M., Plomp, A. S., Wolterman, R. A., Robanus-Maandag, E. C., Baas, F., & Wesseling, P. (2007) · The American Journal of Human Genetics · doi:10.1086/513207 · Cited by 398
Germline mutations in FH confer predisposition to malignant pheochromocytomas and paragangliomas
Castro-Vega, L. J., Buffet, A., De Cubas, A. A., Cascón, A., Menara, M., Khalifa, E., Amar, L., Azriel, S., Bourdeau, I., Chabre, O., et al. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddt639 · Cited by 397
Wlodarski, M. W., Hirabayashi, S., Pastor, V., Starý, J., Hasle, H., Masetti, R., Dworzak, M., Schmugge, M., van den Heuvel-Eibrink, M., Ussowicz, M., et al. (2016) · Blood · doi:10.1182/blood-2015-09-669937 · Cited by 392
Self-citationVanharanta, S., Buchta, M., McWhinney, S. R., Virta, S. K., Peçzkowska, M., Morrison, C. D., Lehtonen, R., Januszewicz, A., Järvinen, H., Juhola, M., et al. (2004) · The American Journal of Human Genetics · doi:10.1086/381054 · Cited by 389
Germline mutations in TMEM127 confer susceptibility to pheochromocytoma
Qin, Y., Yao, L., King, E. E., Buddavarapu, K., Lenci, R. E., Chocron, E. S., Lechleiter, J. D., Sass, M., Aronin, N., Schiavi, F., et al. (2010) · Nature Genetics · doi:10.1038/ng.533 · Cited by 379
Weren, R. D. A., Ligtenberg, M. J. L., Kets, C. M., de Voer, R. M., Verwiel, E. T. P., Spruijt, L., van Zelst-Stams, W. A. G., Jongmans, M. C., Gilissen, C., Hehir-Kwa, J. Y., et al. (2015) · Nature Genetics · doi:10.1038/ng.3287 · Cited by 378
Niemeyer, C. M., Kang, M. W., Shin, D. H., Furlan, I., Erlacher, M., Bunin, N. J., Bunda, S., Finklestein, J. Z., Sakamoto, K. M., Gorr, T. A., et al. (2010) · Nature Genetics · doi:10.1038/ng.641 · Cited by 374
Self-citationGermline ETV6 mutations in familial thrombocytopenia and hematologic malignancy
Zhang, M. Y., Churpek, J. E., Keel, S. B., Walsh, T., Lee, M. K., Loeb, K. R., Gulsuner, S., Pritchard, C. C., Sanchez-Bonilla, M., Delrow, J. J., et al. (2015) · Nature Genetics · doi:10.1038/ng.3177 · Cited by 367
Germline Mutations of the Paired–Like Homeobox 2B (PHOX2B) Gene in Neuroblastoma
Trochet, D., Bourdeaut, F., Janoueix-Lerosey, I., Deville, A., de Pontual, L., Schleiermacher, G., Coze, C., Philip, N., Frébourg, T., Munnich, A., et al. (2004) · The American Journal of Human Genetics · doi:10.1086/383253 · Cited by 358
Germ-line p53 mutations predispose to a wide spectrum of early-onset cancers.
Nichols, K. E., Malkin, D. M., Garber, J. E., Fraumeni, J. F., & Li, F. P. (2001) · PubMed · Cited by 354
Schneppenheim, R., Frühwald, M. C., Gesk, S., Hasselblatt, M., Jeibmann, A., Kordes, U., Kreuz, M., Leuschner, I., Subero, J. I. M., Obser, T., et al. (2010) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2010.01.013 · Cited by 348
Self-citationWang, L. L., Gannavarapu, A., Kozinetz, C. A., Levy, M. L., Lewis, R. A., Chintagumpala, M. M., Ruiz-Maldanado, R., Contreras-Ruiz, J., Cunniff, C., Erickson, R. P., et al. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/95.9.669 · Cited by 338
Rare missense variants in POT1 predispose to familial cutaneous malignant melanoma
NCI DCEG Cancer Sequencing Working Group, Shi, J., Laboratory, N. D. C. G. R., French Familial Melanoma Study Group, Yang, X. R., Ballew, B., Rotunno, M., Calista, D., Fargnoli, M. C., Ghiorzo, P., et al. (2014) · Nature Genetics · doi:10.1038/ng.2941 · Cited by 331
Noetzli, L., Lo, R. W., Lee-Sherick, A. B., Callaghan, M., Noris, P., Savoia, A., Rajpurkar, M., Jones, K., Gowan, K., Balduini, C. L., et al. (2015) · Nature Genetics · doi:10.1038/ng.3253 · Cited by 331
Narumi, S., Amano, N., Ishii, T., Katsumata, N., Muroya, K., Adachi, M., Toyoshima, K., Tanaka, Y., Fukuzawa, R., Miyako, K., et al. (2016) · Nature Genetics · doi:10.1038/ng.3569 · Cited by 329
Mutation of CEBPA in Familial Acute Myeloid Leukemia
Smith, M. L., Cavenagh, J. D., Lister, T. A., & Fitzgibbon, J. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa041331 · Cited by 328
A recurrent germline PAX5 mutation confers susceptibility to pre-B cell acute lymphoblastic leukemia
Shah, S., Schrader, K. A., Waanders, E., Timms, A. E., Vijai, J., Miething, C., Wechsler, J., Yang, J., Hayes, J., Klein, R. J., et al. (2013) · Nature Genetics · doi:10.1038/ng.2754 · Cited by 327
Bloom's syndrome. XX. The first 100 cancers
German, J. (1997) · Cancer Genetics and Cytogenetics · doi:10.1016/s0165-4608(96)00336-6 · Cited by 317
Piotrowski, A., Xie, J., Liu, Y. F., Poplawski, A. B., Gomes, A. R., Madanecki, P., Fu, C., Crowley, M. R., Crossman, D. K., Armstrong, L., et al. (2014) · Nature Genetics · doi:10.1038/ng.2855 · Cited by 315
T (brachyury) gene duplication confers major susceptibility to familial chordoma
Yang, X. R., Ng, D., Alcorta, D. A., Liebsch, N. J., Sheridan, E., Li, S., Goldstein, A. M., Parry, D. M., & Kelley, M. J. (2009) · Nature Genetics · doi:10.1038/ng.454 · Cited by 305
Smith, M. J., Beetz, C., Williams, S. G., Bhaskar, S. S., O’Sullivan, J., Anderson, B., Daly, S. B., Urquhart, J. E., Bholah, Z., Oudit, D., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2014.58.2569 · Cited by 300
Identification of the von Hippel-Lindau (VHL) gene. Its role in renal cancer
Linehan, W. M. (1995) · JAMA · doi:10.1001/jama.273.7.564 · Cited by 300
Side, L., Taylor, B., Cayouette, M., Conner, E., Thompson, P., Luce, M., & Shannon, K. (1997) · New England Journal of Medicine · doi:10.1056/nejm199706123362404 · Cited by 295
Germline Susceptibility to Colorectal Cancer Due to Base-Excision Repair Gene Defects
Farrington, S. M., Tenesa, A., Barnetson, R., Wiltshire, A., Prendergast, J., Porteous, M., Campbell, H., & Dunlop, M. G. (2005) · The American Journal of Human Genetics · doi:10.1086/431213 · Cited by 293
Germline PHOX2B Mutation in Hereditary Neuroblastoma
Mosse, Y. P., Laudenslager, M., Khazi, D., Carlisle, A. J., Winter, C. L., Rappaport, E., & Maris, J. M. (2004) · The American Journal of Human Genetics · doi:10.1086/424530 · Cited by 284
Constitutional and somatic rearrangement of chromosome 21 in acute lymphoblastic leukaemia
Li, Y., Schwab, C., Ryan, S. L., Papaemmanuil, E., Robinson, H. M., Jacobs, P., Moorman, A. V., Dyer, S., Borrow, J., Griffiths, M., et al. (2014) · Nature · doi:10.1038/nature13115 · Cited by 280
Germline BAP1 Mutations Predispose to Renal Cell Carcinomas
Popova, T., Hebert, L., Jacquemin, V., Gad, S., Caux-Moncoutier, V., Dubois-d’Enghien, C., Richaudeau, B., Renaudin, X., Sellers, J., Nicolas, A., et al. (2013) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2013.04.012 · Cited by 279
Risk of tumorigenesis in overgrowth syndromes: a comprehensive review
Lapunzina, P. (2005) · American Journal of Medical Genetics Part C Seminars in Medical Genetics · doi:10.1002/ajmg.c.30064 · Cited by 276 · cited 1×
“In addition, patientswith isolated hemihyperplasia (MIM 235000) have an increased WT risk (Dempsey-Robertson, Wilkes, Stall, & Bush, 2012; Hoyme et al., 1998; Lapunzina, 2005).”
BackgroundLynch, E. D., Ostermeyer, E. A., Lee, M. K., Arena, J. F., Ji, H., Dann, J., Swisshelm, K., Suchard, D., MacLeod, P. M., Kvinnsland, S., et al. (1997) · The American Journal of Human Genetics · doi:10.1086/301639 · Cited by 276
Identification of Germline and Somatic Mutations Affecting the Retinoblastoma Gene
Dunn, J. M., Phillips, R. A., Becker, A. J., & Gallie, B. L. (1988) · Science · doi:10.1126/science.3175621 · Cited by 265
Management of the patient and family with neurofibromatosis 2: a consensus conference statement
Evans, D., Baser, M., O'Reilly, B., Rowe, J., Gleeson, M., Saeed, S., King, A., Huson, S., Kerr, R., Thomas, N., et al. (2005) · British Journal of Neurosurgery · doi:10.1080/02688690500081206 · Cited by 261
Loss-of-function mutations in SMARCE1 cause an inherited disorder of multiple spinal meningiomas
Smith, M. J., O'Sullivan, J., Bhaskar, S. S., Hadfield, K. D., Poke, G., Caird, J., Sharif, S., Eccles, D., Fitzpatrick, D., Rawluk, D., et al. (2013) · Nature Genetics · doi:10.1038/ng.2552 · Cited by 261
Pituitary blastoma: a pathognomonic feature of germ-line DICER1 mutations
de Kock, L., Sabbaghian, N., Plourde, F., Srivastava, A., Weber, E., Bouron-Dal Soglio, D., Hamel, N., Choi, J. H., Park, S.-H., Deal, C. L., et al. (2014) · Acta Neuropathologica · doi:10.1007/s00401-014-1285-z · Cited by 259
Zhou, X.-P., Woodford-Richens, K., Lehtonen, R., Kurose, K., Aldred, M., Hampel, H., Launonen, V., Virta, S., Pilarski, R., Salovaara, R., et al. (2001) · The American Journal of Human Genetics · doi:10.1086/323703 · Cited by 253
Suarez, F., Mahlaoui, N., Canioni, D., Andriamanga, C., Dubois d'Enghien, C., Brousse, N., Jais, J.-P., Fischer, A., Hermine, O., & Stoppa-Lyonnet, D. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.56.5101 · Cited by 251
Adam, R., Spier, I., Zhao, B., Kloth, M., Marquez, J., Hinrichsen, I., Kirfel, J., Tafazzoli, A., Horpaopan, S., Uhlhaas, S., et al. (2016) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2016.06.015 · Cited by 251
Germline mutations in DIS3L2 cause the Perlman syndrome of overgrowth and Wilms tumor susceptibility
Astuti, D., Morris, M. R., Cooper, W. N., Staals, R. H. J., Wake, N. C., Fews, G. A., Gill, H., Gentle, D., Shuib, S., Ricketts, C. J., et al. (2012) · Nature Genetics · doi:10.1038/ng.1071 · Cited by 250
Loss of B Cells in Patients with Heterozygous Mutations in IKAROS
Kuehn, H. S., Boisson, B., Cunningham-Rundles, C., Reichenbach, J., Stray-Pedersen, A., Gelfand, E. W., Maffucci, P., Pierce, K. R., Abbott, J. K., Voelkerding, K. V., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1512234 · Cited by 244
Owen, C. J., Toze, C. L., Koochin, A., Forrest, D. L., Smith, C. A., Stevens, J. M., Jackson, S. C., Poon, M.-C., Sinclair, G. D., Leber, B., et al. (2008) · Blood · doi:10.1182/blood-2008-05-156745 · Cited by 242
PDGFRA germline mutation in a family with multiple cases of gastrointestinal stromal tumor
Chompret, A., Kannengiesser, C., Barrois, M., Terrier, P., Dahan, P., Tursz, T., Lenoir, G. M., & Bressac-De Paillerets, B. (2004) · Gastroenterology · doi:10.1053/j.gastro.2003.10.079 · Cited by 237
Lessel, D., Vaz, B., Halder, S., Lockhart, P. J., Marinovic-Terzic, I., Lopez-Mosqueda, J., Philipp, M., Sim, J. C. H., Smith, K. R., Oehler, J., et al. (2014) · Nature Genetics · doi:10.1038/ng.3103 · Cited by 236
Waguespack, S. G., Rich, T., Grubbs, E., Ying, A. K., Perrier, N. D., Ayala-Ramirez, M., & Jimenez, C. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2830 · Cited by 232
Neurofibromatosis type 1 (NF1)
(2013) · Handbook of Clinical Neurology · doi:10.1016/b978-0-444-52902-2.00053-9 · Cited by 231
Wasserman, J. D., Novokmet, A., Eichler-Jonsson, C., Ribeiro, R. C., Rodriguez-Galindo, C., Zambetti, G. P., & Malkin, D. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2013.52.6863 · Cited by 227
Moshous, D., Pannetier, C., Chasseval, R. D., Deist, F. L., Cavazzana-Calvo, M., Romana, S., Macintyre, E., Canioni, D., Brousse, N., Fischer, A., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci16774 · Cited by 227
MAPK pathway activation in pilocytic astrocytoma
Jones, D. T. W., Gronych, J., Lichter, P., Witt, O., & Pfister, S. M. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-011-0898-9 · Cited by 225
Self-citationIsozaki, K., Terris, B., Belghiti, J., Schiffmann, S., Hirota, S., & Vanderwinden, J.-M. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64795-5 · Cited by 223
Kratz, C. P., Franke, L., Peters, H., Kohlschmidt, N., Kazmierczak, B., Finckh, U., Bier, A., Eichhorn, B., Blank, C., Kraus, C., et al. (2015) · British Journal of Cancer · doi:10.1038/bjc.2015.75 · Cited by 217
Self-citationWagner, J. E. (2004) · Blood · doi:10.1182/blood-2003-09-3138 · Cited by 214
Monogenic and polygenic determinants of sarcoma risk: an international genetic study
Ballinger, M. L., Goode, D. L., Ray-Coquard, I., James, P. A., Mitchell, G., Niedermayr, E., Puri, A., Schiffman, J. D., Dite, G. S., Cipponi, A., et al. (2016) · The Lancet Oncology · doi:10.1016/s1470-2045(16)30147-4 · Cited by 213
Hof, J., Krentz, S., van Schewick, C., Körner, G., Shalapour, S., Rhein, P., Karawajew, L., Ludwig, W.-D., Seeger, K., Henze, G., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2011.34.8144 · Cited by 208
Self-citationDICER1 mutations in childhood cystic nephroma and its relationship to DICER1-renal sarcoma
Doros, L. A., Rossi, C. T., Yang, J., Field, A., Williams, G. M., Messinger, Y., Cajaiba, M. M., Perlman, E. J., A Schultz, K., Cathro, H. P., et al. (2014) · Modern Pathology · doi:10.1038/modpathol.2013.242 · Cited by 208
Identification of the von Hippel-Lindau (VHL) Gene: Its Role in Renal Cancer
Linehan, W. M. (1995) · JAMA · doi:10.1001/jama.1995.03520310062031 · Cited by 207
Mutations in PDGFRB Cause Autosomal-Dominant Infantile Myofibromatosis
Martignetti, J. A., Tian, L., Li, D., Ramirez, M. C. M., Camacho-Vanegas, O., Camacho, S. C., Guo, Y., Zand, D. J., Bernstein, A. M., Masur, S. K., et al. (2013) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2013.04.024 · Cited by 206
Moriyama, T., Metzger, M. L., Wu, G., Nishii, R., Qian, M., Devidas, M., Yang, W., Cheng, C., Cao, X., Quinn, E., et al. (2015) · The Lancet Oncology · doi:10.1016/s1470-2045(15)00369-1 · Cited by 205
Shared Genetic Susceptibility to Breast Cancer, Brain Tumors, and Fanconi Anemia
Offit, K., Levran, O., Mullaney, B., Mah, K., Nafa, K., Batish, S. D., Diotti, R., Schneider, H., Deffenbaugh, A., Scholl, T., et al. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djg072 · Cited by 201
Self-citationMolecular defect of RAPADILINO syndrome expands the phenotype spectrum of RECQL diseases
Siitonen, H. A. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg306 · Cited by 195
Tumor predisposition in Costello syndrome
Gripp, K. W. (2005) · American Journal of Medical Genetics Part C: Seminars in Medical Genetics · doi:10.1002/ajmg.c.30065 · Cited by 193
Recognition of genetic predisposition in pediatric cancer patients: An easy-to-use selection tool
Jongmans, M. C. J., Loeffen, J. L. C. M., Waanders, E., Hoogerbrugge, P. M., Ligtenberg, M. J. L., Kuiper, R. P., & Hoogerbrugge, N. (2016) · European Journal of Medical Genetics · doi:10.1016/j.ejmg.2016.01.008 · Cited by 193
Gene encoding a new RING-B-box-Coiled-coil protein is mutated in mulibrey nanism
Avela, K., Lipsanen-Nyman, M., Idänheimo, N., Seemanová, E., Rosengren, S., Mäkelä, T. P., Perheentupa, J., Chapelle, A. D. L., & Lehesjoki, A.-E. (2000) · Nature Genetics · doi:10.1038/77053 · Cited by 191
Hoyme, H. E., Seaver, L. H., Jones, K. L., Procopio, F., Crooks, W., & Feingold, M. (1998) · American Journal of Medical Genetics · doi:10.1002/(sici)1096-8628(19981002)79:4<274::aid-ajmg8>3.0.co;2-m · Cited by 191
Identification of a SUFU germline mutation in a family with Gorlin syndrome
Pastorino, L., Ghiorzo, P., Nasti, S., Battistuzzi, L., Cusano, R., Marzocchi, C., Garrè, M. L., Clementi, M., & Scarrà, G. B. (2009) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.32944 · Cited by 187
Dehner, L. P., Jarzembowski, J. A., & Hill, D. A. (2012) · Modern Pathology · doi:10.1038/modpathol.2011.185 · Cited by 185
ANKRD26-related thrombocytopenia and myeloid malignancies
Noris, P., Favier, R., Alessi, M.-C., Geddis, A. E., Kunishima, S., Heller, P. G., Giordano, P., Niederhoffer, K. Y., Bussel, J. B., Podda, G. M., et al. (2013) · Blood · doi:10.1182/blood-2013-04-499319 · Cited by 182
Clinical and molecular aspects of the Simpson-Golabi-Behmel syndrome
Neri, G., Gurrieri, F., Zanni, G., & Lin, A. (1998) · American Journal of Medical Genetics · doi:10.1002/(sici)1096-8628(19981002)79:4<279::aid-ajmg9>3.0.co;2-h · Cited by 182
Germ-line and somatic DICER1 mutations in pineoblastoma
de Kock, L., Sabbaghian, N., Druker, H., Weber, E., Hamel, N., Miller, S., Choong, C. S., Gottardo, N. G., Kees, U. R., Rednam, S. P., et al. (2014) · Acta Neuropathologica · doi:10.1007/s00401-014-1318-7 · Cited by 179
Cancer risk in patients with Noonan syndrome carrying a PTPN11 mutation
Jongmans, M. C. J., van der Burgt, I., Hoogerbrugge, P. M., Noordam, K., Yntema, H. G., Nillesen, W. M., Kuiper, R. P., Ligtenberg, M. J., van Kessel, A. G., van Krieken, J. H. J., et al. (2011) · European Journal of Human Genetics · doi:10.1038/ejhg.2011.37 · Cited by 178
Ataxia-Pancytopenia Syndrome Is Caused by Missense Mutations in SAMD9L
Chen, D.-H., Below, J. E., Shimamura, A., Keel, S. B., Matsushita, M., Wolff, J., Sul, Y., Bonkowski, E., Castella, M., Taniguchi, T., et al. (2016) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2016.04.009 · Cited by 178
Trilateral retinoblastoma: a systematic review and meta-analysis
de Jong, M. C., Kors, W. A., de Graaf, P., Castelijns, J. A., Kivelä, T., & Moll, A. C. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70336-5 · Cited by 177
A Recurrent PDGFRB Mutation Causes Familial Infantile Myofibromatosis
Cheung, Y. H., Gayden, T., Campeau, P. M., LeDuc, C. A., Russo, D., Nguyen, V.-H., Guo, J., Qi, M., Guan, Y., Albrecht, S., et al. (2013) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2013.04.026 · Cited by 174
Preudhomme, C., Renneville, A., Bourdon, V., Philippe, N., Roche-Lestienne, C., Boissel, N., Dhedin, N., André, J.-M., Cornillet-Lefebvre, P., Baruchel, A., et al. (2009) · Blood · doi:10.1182/blood-2008-07-168260 · Cited by 173
Melanocortin-1 Receptor Variant R151C Modifies Melanoma Risk in Dutch Families with Melanoma
van der Velden, P. A., Sandkuijl, L. A., Bergman, W., Pavel, S., van Mourik, L., Frants, R. R., & Gruis, N. A. (2001) · The American Journal of Human Genetics · doi:10.1086/323411 · Cited by 173
Immunodeficiency-associated lymphomas
Tran, H., Nourse, J., Hall, S., Green, M., Griffiths, L., & Gandhi, M. K. (2008) · Blood Reviews · doi:10.1016/j.blre.2008.03.009 · Cited by 172
Constitutional mismatch repair-deficiency syndrome
Wimmer, K., & Kratz, C. P. (2010) · Haematologica · doi:10.3324/haematol.2009.021626 · Cited by 172
Self-citationDoros, L., Yang, J., Dehner, L., Rossi, C. T., Skiver, K., Jarzembowski, J. A., Messinger, Y., Schultz, K. A., Williams, G., André, N., et al. (2012) · Pediatric Blood & Cancer · doi:10.1002/pbc.24020 · Cited by 167
Loss of SUFU Function in Familial Multiple Meningioma
Aavikko, M., Li, S.-P., Saarinen, S., Alhopuro, P., Kaasinen, E., Morgunova, E., Li, Y., Vesanen, K., Smith, M. J., Evans, D. G. R., et al. (2012) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2012.07.015 · Cited by 161
Germline ETV6 Mutations Confer Susceptibility to Acute Lymphoblastic Leukemia and Thrombocytopenia
Topka, S., Vijai, J., Walsh, M. F., Jacobs, L., Maria, A., Villano, D., Gaddam, P., Wu, G., McGee, R. B., Quinn, E., et al. (2015) · PLOS Genetics · doi:10.1371/journal.pgen.1005262 · Cited by 159
Mussa, A., Molinatto, C., Baldassarre, G., Riberi, E., Russo, S., Larizza, L., Riccio, A., & Ferrero, G. B. (2016) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2016.05.038 · Cited by 158
Gripp, K. W., Scott, C. I., Nicholson, L., McDonald‐McGinn, D. M., Ozeran, J. D., Jones, M. C., Lin, A. E., & Zackai, E. H. (2002) · American Journal of Medical Genetics · doi:10.1002/ajmg.10241 · Cited by 156
Germline TP53 Variants and Susceptibility to Osteosarcoma
Mirabello, L., Yeager, M., Mai, P. L., Gastier-Foster, J. M., Gorlick, R., Khanna, C., Patiño-Garcia, A., Sierrasesúmaga, L., Lecanda, F., Andrulis, I. L., et al. (2015) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djv101 · Cited by 155
Hoyme, H. E., Seaver, L. H., Jones, K. L., Procopio, F., Crooks, W., & Feingold, M. (1998) · American Journal of Medical Genetics · Cited by 149
Germline duplication of ATG2B and GSKIP predisposes to familial myeloid malignancies
Saliba, J., Saint‐Martin, C., Stefano, A. D., Lenglet, G., Marty, C., Keren, B., Pasquier, F., Della-Valle, V., Secardin, L., Leroy, G., et al. (2015) · Nature Genetics · doi:10.1038/ng.3380 · Cited by 148
Martín‐Lorenzo, A., Hauer, J., Vicente‐Dueñas, C., Auer, F., González‐Herrero, I., García‐Ramírez, I., Ginzel, S., Thiele, R., Constantinescu, S. N., Bartenhagen, C., et al. (2015) · Cancer Discovery · doi:10.1158/2159-8290.cd-15-0892 · Cited by 144
Self-citationAretz, S., Koch, A., Uhlhaas, S., Friedl, W., Propping, P., von Schweinitz, D., & Pietsch, T. (2005) · Pediatric Blood & Cancer · doi:10.1002/pbc.20698 · Cited by 140
Anaplastic rhabdomyosarcoma in TP53 germline mutation carriers
Hettmer, S., Archer, N. M., Somers, G. R., Novokmet, A., Wagers, A. J., Diller, L., Galindo, C. R., Teot, L. A., & Malkin, D. M. (2013) · Cancer · doi:10.1002/cncr.28507 · Cited by 135
Self-citationLipton, J. M. M., Federman, N. C., Khabbaze, Y., Schwartz, C. L., Hilliard, L., Clark, J. I., & Vlachos, A. (2001) · The American journal of pediatric hematology/oncology · doi:10.1097/00043426-200101000-00009 · Cited by 134
Genetic loss of SH2B3 in acute lymphoblastic leukemia
Pérez-García, A., Ambesi‐Impiombato, A., Hadler, M., Rigo, I., LeDuc, C. A., Kelly, K. M., Jalas, C., Paietta, E. M., Racevskis, J., Rowe, J. M., et al. (2013) · Blood · doi:10.1182/blood-2013-05-500850 · Cited by 130
Ketteler, P., Arendt, M., Viehmann, A., Eisele, L., Guin, C. H. D. L., Schündeln, M. M., Biewald, E. M., Astrahantseff, K., Wieland, R., Bornfeld, N., et al. (2016) · Pediatric Blood & Cancer · doi:10.1002/pbc.26193 · Cited by 130
Self-citationDICER1 Mutations and Differentiated Thyroid Carcinoma: Evidence of a Direct Association
Rutter, M. M., Jha, P., Schultz, K. A. P., Sheil, A. T., Harris, A. K., Bauer, A. J., Field, A. L., Geller, J. I., & Hill, D. A. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-2169 · Cited by 128
Reid, S., Renwick, A., Seal, S., Baskcomb, L., Barfoot, R., Jayatilake, H., Pritchard‐Jones, K., Stratton, M. R., Ridolfi-Lüthy, A., & Rahman, N. (2005) · Journal of Medical Genetics · doi:10.1136/jmg.2004.022673 · Cited by 124
DICER1 hotspot mutations in non-epithelial gonadal tumours
Witkowski, L., Mattina, J., Schönberger, S., Murray, M. J., Huntsman, D. D., Reis-Filho, J. S., McCluggage, W. G., Nicholson, J. C., Coleman, N., Calaminus, G., et al. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.637 · Cited by 123
Self-citationMeningiomas May Be a Component Tumor of Multiple Endocrine Neoplasia Type 1
Asgharian, B., Chen, Y., Patronas, N. J., Peghini, P. L., Reynolds, J. C., Vortmeyer, A. O., Zhuang, Z., Venzon, D. J., Gibril, F., & Jensen, R. T. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-0938-3 · Cited by 123
Molecular Characterization of Choroid Plexus Tumors Reveals Novel Clinically Relevant Subgroups
Merino, D. M., Shlien, A., Villani, A., Pieńkowska, M., Mack, S. C., Ramaswamy, V., Shih, D. J. H., Tatevossian, R., Novokmet, A., Choufani, S., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-1324 · Cited by 122
Self-citationKirwan, M., Walne, A. J., Plagnol, V., Velangi, M., Ho, A. Y. L., Hossain, U., Vulliamy, T., & Dokal, I. S. (2012) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2012.03.020 · Cited by 121
Sei, Y., Zhao, X., Forbes, J., Szymczak, S., Li, Q., Trivedi, A., Voellinger, M., Joy, G., Feng, J., Whatley, M., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.04.008 · Cited by 119
Ngan, E., Lang, B. H., Liu, T., Shum, C. K. Y., So, M.-T., Lau, D. K., Leon, T. Y. Y., Cherny, S. S., Tsai, S. Y., Lo, C., et al. (2009) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djn471 · Cited by 115
Haematopoietic development and leukaemia in D own syndrome
Roberts, I. A. G., & Izraeli, S. (2014) · British Journal of Haematology · doi:10.1111/bjh.13096 · Cited by 111
Occurrence of B-cell lymphomas in patients with activated phosphoinositide 3-kinase δ syndrome
Kracker, S., Curtis, J. W., Ibrahim, M. A. A., Šedivá, A., Salisbury, J. R., Campr, V., Debré, M., Edgar, D., Imai, K., Pïcard, C., et al. (2014) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2014.02.020 · Cited by 109
Hughes-Benzie, R., Hunter, A. G. W., Allanson, J. E., et al. (1992) · American Journal of Medical Genetics · doi:10.1002/ajmg.1320430165 · Cited by 108
Pfaff, E., Remke, M., Sturm, D., Benner, A., Witt, H., Milde, T., von Bueren, A. O., Wittmann, A., Schöttler, A., Jorch, N., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2010.31.1670 · Cited by 107
Self-citationSubmicroscopic deletions at the WAGR locus, revealed by nonradioactive in situ hybridization.
Fantes, J. A., Bickmore, W. A., Fletcher, J. M., Ballesta, F., Hanson, I. M., & van Heyningen, V. (1992) · Europe PMC (PubMed Central) · Cited by 105
Brain tumors in individuals with familial adenomatous polyposis
Attard, T. M., Giglio, P., Koppula, S., et al. (2007) · Cancer · doi:10.1002/cncr.22475 · Cited by 105
Little, S. E., Hanks, S., King‐Underwood, L., Jones, C., Rapley, E. A., Rahman, N., & Pritchard‐Jones, K. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.02.136 · Cited by 104
Large-cell calcifying Sertoli cell tumors of the testes in pediatrics
Gourgari, E., Saloustros, E. S., & Stratakis, C. A. (2012) · Current Opinion in Pediatrics · doi:10.1097/mop.0b013e328355a279 · Cited by 100
Molven, A., Grimstvedt, M. B., Steine, S. J., Harland, M., Avril, M., Hayward, N. K., & Akslen, L. A. (2005) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20202 · Cited by 100
Chen, Z., Moran, K. A., Richards‐Yutz, J., Toorens, E., Gerhart, D., Ganguly, T., Shields, C. L., & Ganguly, A. A. (2013) · Human Mutation · doi:10.1002/humu.22488 · Cited by 100
Germline Mutations in the CDKN2B Tumor Suppressor Gene Predispose to Renal Cell Carcinoma
Jafri, M., Wake, N. C., Ascher, D. B., Pires, D. E. V., Gentle, D., Morris, M. R., Rattenberry, E., Simpson, M. A., Trembath, R. C., Weber, A. P., et al. (2015) · Cancer Discovery · doi:10.1158/2159-8290.cd-14-1096 · Cited by 99
Twigg, S. R. F., Hufnagel, R. B., Miller, K. A., Zhou, Y., McGowan, S. J., Taylor, J., Craft, J., Taylor, J. C., Santoro, S. L., Huang, T., et al. (2016) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2016.04.007 · Cited by 99
Genetic mutations in sporadic pituitary adenomas—what to screen for?
Lecoq, A.-L., Kamenický, P., Guiochon‐Mantel, A., & Chanson, P. (2014) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2014.181 · Cited by 98
Inherited susceptibility to pre B-ALL caused by germline transmission of PAX5 c.547G>A
Auer, F., Rüschendorf, F., Gombert, M., Husemann, P., Ginzel, S., Izraeli, S., Harit, M., Weintraub, M., Weinstein, O. Y., Lerer, I., et al. (2013) · Leukemia · doi:10.1038/leu.2013.363 · Cited by 96
Self-citationMabula, J. B., Chalya, P. L., Mchembe, M. D., Jaka, H., Giiti, G. C., Rambau, P., Masalu, N. A., Kamugisha, E., Ssentongo, R., & Gilyoma, J. M. (2012) · BMC Dermatology · doi:10.1186/1471-5945-12-5 · Cited by 92
At-Risk Populations for Osteosarcoma: The Syndromes and Beyond
Calvert, G. T., Randall, R. L., Jones, K. B., Cannon-Albright, L., Lessnick, S., & Schiffman, J. D. (2012) · Sarcoma · doi:10.1155/2012/152382 · Cited by 90
Flotho, C., Steinemann, D., Mullighan, C. G., Neale, G. A. M., Mayer, K., Kratz, C. P., Schlegelberger, B., Downing, J. R., & Niemeyer, C. M. (2007) · Oncogene · doi:10.1038/sj.onc.1210361 · Cited by 88
Self-citationLoss of GATA‐1 full length as a cause of Diamond–Blackfan anemia phenotype
Parrella, S., Aspesi, A., Quarello, P., Garelli, E., Pavesi, E., Carando, A., Nardi, M., Ellis, S. R., Ramenghi, U., & Dianzani, I. (2014) · Pediatric Blood & Cancer · doi:10.1002/pbc.24944 · Cited by 87
Klein, S. D., Lee, H., Ghahremani, S., Kempert, P., Ischander, M. M., Teitell, M. A., Nelson, S. F., & Martínez-Agosto, J. A. (2014) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2013-101943 · Cited by 85
Attarbaschi, A., Carraro, E., Abla, O., Barzilai-Birenboim, S., Bomken, S. N., Brugières, L., Bubanská, E., Burkhardt, B., Chiang, A., Csóka, M., et al. (2016) · Haematologica · doi:10.3324/haematol.2016.147116 · Cited by 84
Self-citationKijima, C., Miyashita, T., Suzuki, M., Oka, H., & Fujii, K. (2012) · Familial Cancer · doi:10.1007/s10689-012-9548-0 · Cited by 83
Mutations in the transcriptional repressor REST predispose to Wilms tumor
Mahamdallie, S., Hanks, S., Karlin, K. L., Zachariou, A., Perdeaux, E. R., Ruark, E., Shaw, C. A., Renwick, A., Ramsay, E., Yost, S. E., et al. (2015) · Nature Genetics · doi:10.1038/ng.3440 · Cited by 83
The p53 gene in pediatric therapy-related leukemia and myelodysplasia
Felix, C., Hosler, M. R., Provisor, D., Salhany, K., Sexsmith, E., Slater, D., Cheung, N., Winick, N., Strauss, E., Heyn, R. M., et al. (1996) · Blood · doi:10.1182/blood.v87.10.4376.bloodjournal87104376 · Cited by 80
Chaubert, P., Gayer, R., Zimmermann, A., Fontolliet, C., Stamm, B., Bosman, F. T., & Shaw, P. H. (1997) · Hepatology · doi:10.1002/hep.510250613 · Cited by 80
Pereira, J. S., da Silva, J. G., Tomaz, R. A., Pinto, A. E., Bugalho, M. J., Leite, V. A. P. H., & Cavaco, B. M. (2014) · Endocrine · doi:10.1007/s12020-014-0470-0 · Cited by 76
Alter, B. P., Giri, N., Savage, S. A., Quint, W. G. V., de Koning, M. N. C., & SCHIFFMAN, M. H. (2013) · International Journal of Cancer · doi:10.1002/ijc.28157 · Cited by 74
Wimmer, K., Beilken, A., Nustede, R., Ripperger, T., Lamottke, B., Ure, B., Steinmann, D., Reineke‐Plaaß, T., Lehmann, U., Zschocke, J., et al. (2016) · Familial Cancer · doi:10.1007/s10689-016-9925-1 · Cited by 74
Self-citationLee, P., Bhansali, R. S., Izraeli, S., Hijiya, N., & Crispino, J. D. (2016) · Leukemia · doi:10.1038/leu.2016.164 · Cited by 73
Rhabdomyosarcomas in children with neurofibromatosis type I: A national historical cohort
Crucis, A., Richer, W., Brugières, L., Bergeron, C., Marie‐Cardine, A., Stephan, J., Girard, P., Corradini, N., Münzer, M., Lacour, B., et al. (2015) · Pediatric Blood & Cancer · doi:10.1002/pbc.25556 · Cited by 71
Tumor spectrum in children with Noonan syndrome and SOS1 or RAF1 mutations
Denayer, E., Devriendt, K., de Ravel, T. J. L., Buggenhout, G. V., Smeets, E., François, I., Sznajer, Y., Craen, M., Leventopoulos, G., Mutesa, L., et al. (2009) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20735 · Cited by 71
Gruner, B. A., DeNapoli, T. S., Andrews, W. S., Tomlinson, G. E., Bowman, L. C., & Weitman, S. D. (1998) · Journal of Pediatric Hematology/Oncology · doi:10.1097/00043426-199805000-00018 · Cited by 70
Haliloğlu, G., Jobard, F., Oguz, K., Anlar, B., Akalan, N., Coşkun, T., Sass, J. O., Fischer, J., & Topcu, M. (2008) · Neuropediatrics · doi:10.1055/s-2008-1081217 · Cited by 69
Lohmann, D. R. (2010) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-6448-9_21 · Cited by 69
Self-citationRussell, B. E., Johnston, J. J., Biesecker, L. G., Kramer, N., Pickart, A. M., Rhead, W. J., Tan, W., Brownstein, C. A., Clarkson, L. K., Dobson, A., et al. (2015) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.37131 · Cited by 64
Familial islet cell tumors in von Hippel-Lindau's disease
Hull, M. T., Warfel, K. A., Muller, J., & Higgins, J. T. (1979) · Cancer · doi:10.1002/1097-0142(197910)44:4<1523::aid-cncr2820440452>3.0.co;2-0 · Cited by 61
Steinhagen, E. F., Guillem, J. G., Chang, G., Salo‐Mullen, E. E., Shia, J., Fish, S. A., Stadler, Z. K., & Markowitz, A. J. (2012) · Clinical Colorectal Cancer · doi:10.1016/j.clcc.2012.01.006 · Cited by 58
Halkud, R., Shenoy, A. M., Naik, S. M., Chavan, P., Sidappa, K., & Biswas, S. (2014) · Indian Journal of Surgical Oncology · doi:10.1007/s13193-014-0307-6 · Cited by 55
Chao, M. M., Todd, M. A. M., Kontny, U., Neas, K. R., Sullivan, M. J., Hunter, A. G. W., Picketts, D. J., & Kratz, C. P. (2010) · Pediatric Blood & Cancer · doi:10.1002/pbc.22574 · Cited by 53
Self-citationHidden association of Cowden syndrome, PTEN mutation and meningioma frequency
Yakubov, E., Ghoochani, A., Buslei, R., Buchfelder, M., Eyüpoglu, I. Y., & Savaskan, N. E. (2016) · Oncoscience · doi:10.18632/oncoscience.305 · Cited by 53
Cassiman, D. M., Libbrecht, L. J., Verslype, C., Meersseman, W., Troisi, R. I., Zucman‐Rossi, J., & Vlierberghe, H. V. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.03.002 · Cited by 52
POLE mutations in families predisposed to cutaneous melanoma
Aoude, L. G., Heitzer, E., Johansson, P. A., Gartside, M. G., Wadt, K., Pritchard, A. L., Palmer, J. M., Symmons, J., Gerdes, A., Montgomery, G. W., et al. (2015) · Familial Cancer · doi:10.1007/s10689-015-9826-8 · Cited by 51
Vilarinho, S., Erson-Omay, Z., Harmancı, A. S., Morotti, R. A., Carrión-Grant, G., Baranoski, J. F., Knisely, A. S., Ekong, U. D., Emre, S., Yasuno, K., et al. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.07.003 · Cited by 51
Ulbright, T. M., & Young, R. H. (2014) · Seminars in Diagnostic Pathology · doi:10.1053/j.semdp.2014.07.001 · Cited by 49
Predisposition to Pediatric and Hematologic Cancers: A Moving Target
Malkin, D. M., Nichols, K. E., Zelley, K., & Schiffman, J. D. (2014) · American Society of Clinical Oncology Educational Book · doi:10.14694/edbook_am.2014.34.e44 · Cited by 47
Hepatoblastoma and heart transplantation in a patient with cardio‐facio‐cutaneous syndrome
Al‐Rahawan, M. M., Chute, D. J., Sol‐Church, K., Gripp, K. W., Stabley, D. L., McDaniel, N. L., Wilson, W. G., & Waldron, P. E. (2007) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.31819 · Cited by 47
Acute lymphoblastic leukemia in the context of RASopathies
Cavé, H., Caye‐Eude, A., Strullu, M., Aladjidi, N., Vignal, C., Ferster, A., Mechinaud, F. M., Domenech, C., Pierri, F., Contet, A., et al. (2016) · European Journal of Medical Genetics · doi:10.1016/j.ejmg.2016.01.003 · Cited by 46
Self-citationConstitutional abnormalities of chromosome 21 predispose to iAMP21-acute lymphoblastic leukaemia
Harrison, C. J., & Schwab, C. J. (2016) · European Journal of Medical Genetics · doi:10.1016/j.ejmg.2016.01.006 · Cited by 46
Next generation sequencing in sporadic retinoblastoma patients reveals somatic mosaicism
Amitrano, S., Marozza, A., Somma, S., Imperatore, V., Hadjistilianou, T., Francesco, S. D., Toti, P., Galimberti, D., Meloni, I., Cetta, F., et al. (2015) · European Journal of Human Genetics · doi:10.1038/ejhg.2015.6 · Cited by 44
Identification of GALNT14 as a novel neuroblastoma predisposition gene
Mariano, M. D., Gallesio, R., Chierici, M., Furlanello, C., Conte, M., Garaventa, A., Croce, M., Ferrini, S., Tonini, G. P., & Longo, L. (2015) · Oncotarget · doi:10.18632/oncotarget.4501 · Cited by 43
Gonadoblastoma in Patients with Ullrich-Turner Syndrome
Zelaya, G., Marti, J. M. L., Marino, R. M., de Dávila, M. T. G., & Gallego, M. S. (2014) · Pediatric and Developmental Pathology · doi:10.2350/14-08-1539-oa.1 · Cited by 43
Treatment of acute leukemia in children with ataxia telangiectasia (A-T)
Schoenaker, M. H. D., Suárez, F., Szczepański, T., Mahlaoui, N., & Loeffen, J. L. C. (2016) · European Journal of Medical Genetics · doi:10.1016/j.ejmg.2016.05.012 · Cited by 42
McWilliams, G. D., SantaCruz, K. S., Hart, B. L., & Clericuzio, C. L. (2015) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.37379 · Cited by 38
Do patients with tuberous sclerosis complex have an increased risk for malignancies?
Peron, A., Vignoli, A., Briola, F. L., Volpi, A., Montanari, E., Morenghi, E., Ghelma, F., Bulfamante, G., Cefalo, G., & Canevini, M. P. (2016) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.37644 · Cited by 38
Noonan syndrome, the SOS1 gene and embryonal rhabdomyosarcoma
Jongmans, M. C. J., Hoogerbrugge, P. M., Hilkens, L., Flucke, U. E., van der Burgt, I., Noordam, C., Ruiterkamp‐Versteeg, M., Yntema, H. G., Nillesen, W. M., Ligtenberg, M. J. L., et al. (2010) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20773 · Cited by 36
Kuhlen, M., & Borkhardt, A. (2015) · European Journal of Pediatrics · doi:10.1007/s00431-015-2565-x · Cited by 35
Self-citationIncidence of Abdominal Tumors in Syndromic and Idiopathic Hemihypertrophy/Isolated Hemihyperplasia
Dempsey, M., Wilkes, D. C., Stall, A. C., et al. (2012) · Journal of Pediatric Orthopaedics · doi:10.1097/bpo.0b013e3182471b04 · Cited by 33
Occurrence of Neuroblastoma among TP53 p.R337H Carriers
Seidinger, A. L., Fortes, F. P., Mastellaro, M. J., Cardinalli, I. A., Zambaldi, L. D. J. G., Aguiar, S. S., & Yunes, J. A. (2015) · PLoS ONE · doi:10.1371/journal.pone.0140356 · Cited by 32
Cited by
Mirabello, L., Zhu, B., Koster, R., Karlins, E., Dean, M., Yeager, M., Gianferante, M., Spector, L. G., Morton, L. M., Karyadi, D., et al. (2020) · JAMA Oncology · doi:10.1001/jamaoncol.2020.0197 · Cited by 243
Predisposition to cancer in children and adolescents
Kratz, C. P., Jongmans, M. C., Cavé, H., Wimmer, K., Behjati, S., Guerrini-Rousseau, L., Milde, T., Pajtler, K. W., Golmard, L., Gauthier-Villars, M., et al. (2021) · The Lancet Child & Adolescent Health · doi:10.1016/s2352-4642(20)30275-3 · Cited by 129
Self-citationCancer Progress and Priorities: Childhood Cancer
Lupo, P. J., & Spector, L. G. (2020) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-19-0941 · Cited by 91
Metadata
- Authors
- Ripperger, T., Bielack, S. S., Borkhardt, A., Brecht, I. B., Burkhardt, B., Calaminus, G., Debatin, K., Deubzer, H., Dirksen, U., Eckert, C., Eggert, A., Erlacher, M., Fleischhack, G., Frühwald, M. C., Gnekow, A., Goehring, G., Graf, N., Hanenberg, H., Hauer, J., Hero, B., Hettmer, S., von Hoff, K., Horstmann, M., Hoyer, J., Illig, T., Kaatsch, P., Kappler, R., Kerl, K., Klingebiel, T., Kontny, U., Kordes, U., Körholz, D., Koscielniak, E., Kramm, C. M., Kuhlen, M., Kulozik, A. E., Lamottke, B., Leuschner, I., Lohmann, D. R., Meinhardt, A., Metzler, M., Meyer, L. H., Moser, O., Nathrath, M., Niemeyer, C. M., Nustede, R., Pajtler, K. W., Paret, C., Rasche, M., Reinhardt, D., Rieß, O., Russo, A., Rutkowski, S., Schlegelberger, B., Schneider, D., Schneppenheim, R., Schrappe, M., Schroeder, C., von Schweinitz, D., Simon, T., Sparber‐Sauer, M., Spix, C., Stanulla, M., Steinemann, D., Strahm, B., Temming, P., Thomay, K., von Bueren, A. O., Vorwerk, P., Witt, O., Wlodarski, M., Wössmann, W., Zenker, M., Zimmermann, S., Pfister, S. M., & Kratz, C. P.
- Venue
- American Journal of Medical Genetics Part A
- Publisher
- Wiley
- Published
- 2017-02-07
- Volume
- 173
- Issue
- 4
- Pages
- 1017-1037
- ISSN
- 1552-4825 (ISSN-L)
- 1552-4833
- OpenAlex
- W2586276638
- Cited by
- 283
- References
- 232
- FWCI
- 13.58
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.